[Federal Register Volume 88, Number 67 (Friday, April 7, 2023)]
[Notices]
[Pages 20892-20893]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07333]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Heritable Disorders in
Newborns and Children
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Committee on Heritable Disorders in
Newborns and Children (ACHDNC or Committee) scheduled a public meeting.
Information about ACHDNC and the agenda for this meeting can be found
on the ACHDNC website at https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html.
DATES: Thursday, May 4, 2023, from 9:30 a.m. to 3:00 p.m. Eastern Time
and Friday, May 5, 2023, from 9:30 a.m. to 2:00 p.m. Eastern Time.
ADDRESSES: This meeting will be held in person with an option to join
virtually. While this meeting is open to the public, advance
registration is required. Please visit the ACHDNC website for
information on registration: https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html by the deadline of 12:00 p.m. ET on May
3, 2023. Instructions on how to access the meeting via webcast will be
provided upon registration.
If you are a non-U.S. citizen who would like to attend the May
meeting in-person, please contact [email protected] by April 12, 2023.
FOR FURTHER INFORMATION CONTACT: Alaina Harris, Maternal and Child
Health Bureau, HRSA, 5600 Fishers Lane, Room 18W66, Rockville, Maryland
20857; 301-443-0721; or [email protected].
SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations
to the Secretary of Health and Human Services (Secretary) on the
development of newborn screening activities, technologies, policies,
guidelines, and programs for effectively reducing morbidity and
mortality in newborns and children having, or at risk for, heritable
disorders. ACHDNC reviews and reports regularly on newborn and
childhood screening practices, recommends improvements in the national
newborn and childhood screening programs, and fulfills requirements
stated in the authorizing legislation. In addition, ACHDNC's
recommendations regarding inclusion of additional conditions for
screening on the Recommended Uniform Screening Panel, following
adoption by the Secretary, are evidence-informed preventive health
services provided for in the comprehensive guidelines supported by HRSA
pursuant to section 2713 of the Public Health Service Act (42 U.S.C.
300gg-13). Under this provision, non-grandfathered group health plans
and health insurance issuers offering non-grandfathered group or
individual health insurance are required to provide insurance coverage
without cost-sharing (a co-payment, co-insurance, or deductible) for
preventive services for plan years (i.e., policy years) beginning on or
after the date that is 1 year from the Secretary's adoption of the
condition for screening.
During the May 4-5, 2023, meeting, ACHDNC will hear from experts in
the fields of public health, medicine, heritable disorders, rare
disorders, and newborn screening. Agenda items may include the
following topics:
(1) ACHDNC committee processes including prioritization and
capacity of reviewing initial nominations;
[[Page 20893]]
(2) Criteria for pilot studies related to newborn screening;
(3) Center for Disease Control and Prevention's Enhancing Data
Driven Disease Detection in Newborns (ED3N) Project; and
(4) ACHDNC Decision Matrix.
Agenda items are subject to change as priorities dictate. However,
no votes will be held at this meeting to recommend including additional
conditions for screening to the Recommended Uniform Screening Panel.
Information about ACHDNC, including a roster of members and past
meeting summaries, is also available on ACHDNC's website.
Members of the public also will have the opportunity to provide
comments on any or all of the above agenda items. Public participants
may request to provide general oral comments and may submit written
statements in advance of the scheduled meeting. Oral comments will be
honored in the order they are requested and may be limited as time
allows. Members of the public registered to provide oral public
comments on all other newborn screening related topics are tentatively
scheduled to provide their statements on Friday, May 5, 2023. Requests
to provide a written statement or make oral comments to the ACHDNC must
be submitted via the registration website by 12:00 p.m. ET on
Wednesday, April 19, 2023. Written comments will be shared with the
Committee, so that they have an opportunity to consider them prior to
the meeting.
Individuals who need special assistance or another reasonable
accommodation should notify Alaina Harris at the address and phone
number listed above at least 10 business days prior to the meeting.
Since this meeting occurs in a federal government building,
attendees must go through a security check to enter the building. Non-
U.S. citizen attendees must notify HRSA of their planned attendance at
least 15 business days prior to the meeting in order to facilitate
their entry into the building. All attendees are required to present
government-issued identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-07333 Filed 4-6-23; 8:45 am]
BILLING CODE 4165-15-P